20281 ⎘
Medicinal preparations containing organic active ingredients Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
TREATMENT OF FILAGGRIN (FLG) RELATED DISEASES BY MODULATION OF FLG EXPRESSION AND ACTIVITY
#302Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
#303Formulations for the treatment of pain
#304CRYSTALLINE FORMS AND PROCESSES FOR THE PREPARATION OF PG12 RECEPTOR AGONISTS
#305Polymer-carbohydrate-lipid conjugates
#306POLYMER-CARBOHYDRATE-LIPID CONJUGATES
#307Methods for treating or preventing fatigue
#308Palatable suspending vehicle for pharmaceutical ingredients
#309CENTRAL ADMINISTRATION OF STABLE FORMULATIONS OF THERAPEUTIC AGENTS FOR CNS CONDITIONS
#310Lipid containing formulations
#311COMPOSITIONS AND METHODS FOR DETECTING, TREATING, OR PREVENTING REDUCTIVE STRESS
#312PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION
#313Detection of Histone Deacetylase Inhibition
#314FORMULATIONS OF LADOSTIGIL TARTRATE
#315Cholinesterase Inhibitors for Treating Inflammation
#316INHIBITORS OF EPOXIDE HYDROLASES FOR THE TREATMENT OF HYPERTENSION
#317Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use
#318NEW 5-AMINOLEVULINIC ACID PRODRUGS FOR USE IN PHOTODYNAMIC THERAPY AND PHOTODYNAMIC DIAGNOSIS
#319Antimicrobial compositions
#320METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION
#321COMPOUNDS AND METHODS OF TREATING OBESITY
#322Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease
#323METHODS OF TREATING EPILEPTOGENESIS AND EPILEPSY
#324Preparations and methods for ameliorating or reducing presbyopia
#325AGENTS FOR TREATMENT OF GLAUCOMATOUS RETINOPATHY AND OPTIC NEUROPATHY
#326Method of treating organophosphorous poisoning
#327Rel inhibitors and methods of use thereof
#328Stable aqueous suspension concentrate for delivery of UV-labile water-insoluble biocides
#329Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
#330Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
#331Use and composition for treating dementia
#332Combination of compounds, or a bifunctional compound, that provides fatty acid metabolism and glycolysis inhibition
#333USE OF ANGIOGENESIS ANTAGONISTS IN CONDITIONS OF ABNORMAL VENOUS PROLIFERATION
#334Substituted aminopropionic derivatives as neprilysin inhibitors
#335Aromatic Compositions As Inhibitors Of Exoprotein Production In Non-Absorbent Articles
#336Topical compositions comprising non-proteogenic amino acids and methods of treating skin
#337USE OF KCNQ POTASSIUM CHANNEL OPENERS FOR REDUCING SYMPTOMS OF OR TREATING DISORDERS OR CONDITIONS WHEREIN THE DOPAMINERGIC SYSTEM IS DISRUPTED
#338PDZ DOMAIN MODULATORS
#339METHODS FOR THE TREATMENT OF DEMENTIA BASED ON APO E GENOTYPE
#340Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors
#341Method for modulating microbial quorum sensing
#342TREATMENT OF MITOCHONDRIA-RELATED DISEASES AND IMPROVEMENT OF AGE-RELATED METABOLIC DEFICITS
#343NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION
#344Propargylated aminoindans, processes for preparation, and uses thereof
#345Pharmaceutical compositions of short-acting sedative hypnotic agent
#346Detection of Histone Deacetylase Inhibition
#347Adjuvant for Transdermal or Transmucosal Administration and Pharmaceutical Preparation Containing the Same
#348Auris formulations for treating otic diseases and conditions
#349COMPOSITIONS AND METHODS FOR TREATING ACTIN-MEDIATED MEDICAL CONDITIONS
#350Carisprodol Articles and Methods
#351Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use
#352CENTRAL ADMINISTRATION OF STABLE FORMULATIONS OF THERAPEUTIC AGENTS FOR CNS CONDITIONS
#353METHODS OF USING MENTHOL PROPYLENEGLYCOL-CARBONATE AND ANALOGS THEREOF FOR PRODUCING ANTI-INFLAMMATORY AND ANTI-ANGIOGENIC EFFECTS
#354Enantiomerically resolving acyloxyalkyl thiocarbonates used in synthesizing acyloxyalkyl carbamate prodrugs
#355PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF VIRAL INFECTIONS AND/OR TUMOR DISEASES BY INHIBITING PROTEIN FOLDING AND PROTEIN BREAKDOWN
#356METHODS FOR NEUROPROTECTION
#357Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
#358Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase and inhibitors
#359Stabilized pediatric suspension of carisbamate
#360METHODS OF REDUCING CELL DEATH FOLLOWING HYPOXIA / REOXYGENATION
#361ENZYME REGULATING ETHER LIPID SIGNALING PATHWAYS
#362Methods for Sensitizing Cancer Cells to Inhibitors
#363Lipid containing formulations
#364METHODS FOR TREATING DEPRESSION
#365METHODS FOR THE TREATMENT OF DEMENTIA BASED ON APO E GENOTYPE
#366METHOD OF TREATING INFLAMMATORY ACNE VULGARIS WITH CARBAMIDE PEROXIDE
#367COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISEASE
#368LIQUID CONCENTRATE FOR THE PRESERVATION OF COSMETIC AND PHARMACEUTICAL PRODUCTS
#369Method of treating muscular dystrophies with an inhibitor of histone deacetylase
#370PHENYLALKYL CARBAMATE COMPOSITIONS
#371PHENYLALKYLAMINO CARBAMATE COMPOSITIONS
#372Cholinesterase inhibitors for treating inflammation
#373Method of treating organophosphorous poisoning
#374Use of low-dose ladostigil for neuroprotection
#375Antimicrobial composition of 3-iodo-2-propynylbutyl carbamate and 1,3-butylene glycol as solvent
#376Method for inducing a psychotic state in an animal and a high throughput assay method for identifying a candidate agent having anti-psychotic properties
#377Carisoprodol articles and methods
#378Gelled Periodontal Anesthetic Preparation
#379Method of Treating Cancer Using Dithiocarbamate Derivatives
#380Use of ladostigil for the treatment of schizophrenia
#381Aryl aniline βadrenergic receptor agonists
#382Stable aqueous suspension concentrate for delivery of UV-labile water-insoluble biocides
#383Propargylated aminoindans, processes for preparation, and uses thereof
#384Certain chemical entities, compositions, and methods
#385Non-Absorbent Articles Including Aromatic Compositions As Inhibitors Of Exoprotein Production
#386Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases
#387Use of low-dose ladostigil for neuroprotection
#388Method and composition for treating obesity by targeting cathespin
#389Polyamine conjugates as selective NMDA inhibitors and anti-cancer drugs
#390Method of inhibiting remnant lipoprotein production
#391Treating vulvodynia using prodrugs of GABA analogs
#392Treating premature ejaculation using gabapentin and pregabalin prodrugs
#393Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
#394Cytokine receptor
#395Methods of treating epileptogenesis
#396Methods for neuroprotection
#397Methods for QT interval control
#398Methods and dosage forms for reducing side effects of carbamate compounds
#399Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
#400Antimicrobial composition useful for preserving wood
#401Use of ladostigil for the treatment of multiple sclerosis
#402Agents useful for reducing amylioid precursor protein and treating dementia and methods of use thereof
#403Method for inhibiting lipid absorption and lipid absorption inhibitor
#404Therapeutic modulation of PPARgamma activity
#405Amino acid derivatives
#406Use of nf-kappa b inhibitors for the treatment of mastitis
#407Method and compositions for temporarily incapacitating subjects
#408Method and composition for reducing blood sugar levels or fat storage by targeting cathepsin
#409Methods of identifying therapeutic targets for the treatment of vulvovaginal atrophy
#410Methods of treating epileptogenesis and epilepsy
#411Formulations of ladostigil tartrate
#412Method for the medicinal prophylaxis of cholinesterase inhibitor intoxication, and active substances and medicaments suitable therefor
#413Bambuterol and integrin inhibitor combination and treatment method
#414Substituted aniline derivatives
#415Methods for treating hyperactive gastric motility
#416Anti-coronavirus compounds
#417Methods for the treatment of dementia based on apo e genotype
#418Use of a histone deacetylase inhibitor for treating muscular dystrophies
#419Formulations for the treatment of pain
#420Amino acid derivatives useful for the treatment of alzheimer's disease
#421Dithiocarbamate antiviral agents and methods of using same
#422METHOD FOR MODULATING MICROBIAL QUORUM SENSING
#423Inhibitors of epoxide hydrolases for the treatment of hypertension
#424Palatable suspending vehicle for pharmaceutical ingredients
#425Stabilized antimicrobial agents
#426Method of treating inflammatory acne vulgaris and rosacea with carbamide peroxide
#427Inhibitors of epoxide hydrolases for the treatment of hypertension
#428Peroxide compounds for the prevention and treatment of sexual dysfunction in humans
#429Treatment of myopia
#430Therapeutic modulation of PPARgamma activity
#431Cubic gel particles, uses thereof
#432Antimicrobial compositions
#433Cholinesterase inhibitors for treating inflammation
#434Agents for treatment of glaucomatous retinopathy and optic neuropathy
#435Oxamide inhibitors of plasminogen activator inhibitor-1
#436Liquid concentrate for the preservation of cosmetic and pharmaceutical products
#437Method of treating cancer using dithiocarbamate derivatives
#438Organosulfur inhibitors of tyrosine phosphatases
#439Antimicrobial mixtures comprising iodopropynyl compounds and dimethyldithiocarbamate derivatives
#440Pharmaceutical compositions of short-acting sedative hypnotic agent
#441Methods of extending mammalian life span via iron chelating compounds that reduce free radical damage in mammals
#442Combination comprising S-[2-([[1-(2-ethylbutyl)cyclohexyl] carbonyl]amino)phenyl] 2-methylpropanethioate and an HMG CoA reductase inhibitor
#443Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
#444Extended-release pharmaceutical compositions of Ralinepag
#445Cream that treats pododermatitis
#446Method for treating fungal infections in nails
#447Composition for treating fungal infections in nails